4 June 2026 - The MHRA has today granted a marketing authorisation for the adjuvanted trivalent influenza vaccine (Aujemflu) to protect adults aged 50 and over against flu.

This application was approved under the MHRA’s national assessment procedure.

Read UK Government press release